Stockholders' Equity:
Common stock: par value $0.50 per
share, 120,000,000 shares authorized,
35,908,000, 36,204,000 and 37,760,000
shares outstanding 17,954 18,102 18,880
Additional capital 303,982 288,385 283,448
Retained earnings 531,552 521,438 549,482
Total stockholders' equity 853,488 827,925 851,810
Total $1,912,705 $1,846,716 $1,737,615
Condensed Statements of Consolidated Cash Flows (unaudited)
For the 26 weeks ended
July 31, July 26,
2008 2007
Thousands
Operating Activities:
Net income $51,036 $39,645
Adjustments to reconcile net income to
net cash provided by operating activities:
Depreciation and amortization 51,436 46,543
Provision for store closures
and asset impairments, net (21) 5,772
Deferred income taxes and other (2,543) (3,968)
Stock awards and options, net 8,793 14,162
Excess tax benefits related to
stock awards and options (1,030) (6,570)
Common stock contribution to
benefit plan 13,784 10,224
Changes in assets and liabilities:
Accounts receivable (68,484) (12,492)
Merchandise inventories 45,777 (5,403)
Other assets (1,674) (2,082)
'/>"/>
| SOURCE Longs Drug Stores Corporation Copyright©2008 PR Newswire. All rights reserved |